Adult Stem Cells Are Helping Scleroderma Patients PDF Print E-mail
Wednesday, 20 July 2011 22:37
Dr. Richard Burt and colleagues at Northwestern University have just published a new study in The Lancet that provides more evidence for the success of adult stem cell transplant in treating System Sclerosis (Scleroderma).

Ten patients were treated with their own adult stem cells, and all improved at or before 12 months after treatment, compared with zero of the nine patients that received cyclophosphamide, a chemotherapeutic agent considered the “standard of care” for this disease. None of the adult stem cell-treated patients had their disease worsen, while 8 of the 9 chemo-treated patients showed worsening, and eventually 7 of the chemo patients switched to the adult stem cell treatment.

The researchers note that the adult stem cell treatment improves skin and lung function in these patients for up to 2 years (the length of the current study) and is preferable to the current standard of care.

The new report is accompanied by a commentary by Farge and Gluckman that says the Burt et al. study provides “the best data to date for transplantation in Scleroderma”, and “Despite the small number of patients and short follow-up of ASSIST, the findings of this trial are important for patients with systemic sclerosis, the medical community, and policy makers.”

Dr. Burt is featured in a recently-released video discussing his ideas for use of adult stem cells to treat patients with autoimmune diseases. Burt and his team are using this technique to help treat patients suffering from some 23 different diseases, and the techniques he has developed are now being used in treatment centers around the globe.

Adult stem cells are helping patients now.

Source: Prentice, D. (2011), "Adult Stem Cells Helping Patients With Scleroderma Skin Disease"; Lifenews.com; original article can be viewed here.

 
More articles :

» The Scleroderma Foundation Teams Up with Traitwise

The has teamed up with Austin, TX company, Incorporated, to launch a unique survey to poll thousands of patients and their caregivers. Data from the survey will be shared with researchers nationally and internationally in an effort to improve...

» Calcinosis

Background:The Foundation has recently received some feedback from some members of the public asking for more information regarding the condition known as Calcinosis. As part of our efforts we sought to provide a brief, yet informative insight into...

» Exercise More, Worry Less

Life is full of worries. When you're battling a chronic illness, it seems almost impossible to escape nagging anxieties. When will I feel better? Will my condition worsen? When can I return to work or school?But if you exercise regularly, you will...

» African Americans Have More Severe Complications From Scleroderma

African Americans have more severe complications from systemic sclerosis, also known as scleroderma, than Caucasians. Findings published today in, , a journal of the American College of Rheumatology (ACR), show that compared with Caucasians,...

» Optical Coherence Tomography: The first Quantitative Imaging Biomarker for Scleroderma

Using the , manufactured in the UK by Michelson Diagnostics Ltd, scientists at the Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds have developed the first quantitative imaging biomarker for skin involvement in . Scleroderma...

» Cancer Risk Among Patients With Systemic Sclerosis: A Nationwide Population Study In Taiwan

C-F Kuo, S-F Luo, K-H Yu, I-J Chou, W-Y Tseng, H-C Chang, Y-F Fang, M-J Chiou, L-C SeePosted online on December 11, 2011Objectives: Systemic sclerosis (SSc) has been associated with high cancer risk. We compared the cancer risk among SSc patients...